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doi: 10.1016/j.bpj.2011.06.038The biological relevance of lipid polymorphism has long
been a subject of interest, stemming mainly from the
seminal work of Luzzati (1). The subject has been taken
up again, in particular as it regards the role of cubic phases,
related initially to the crystallization of proteins but later
also to the activity of proteins and peptides (2). Much
more recently, the formation of cubic phases has also been
reported in relation to antimicrobial peptides (3–6)
(AMPs). AMPs are regarded as potential therapeutic agents
to overcome the growing resistance of bacterial strains to
conventional antibiotics (7). Furthermore, they are key
components of the innate and acquired immunity. Although
their antimicrobial action is established, the detailed mech-
anism of action is still prone to discussion. In particular,
although it is known that AMPs can alter the bilayer struc-
ture, and the formation of cubic phases has been reported,
a detailed discussion of this change as an actual possible
mechanism of action is only now being addressed (6) and
is by no means fully understood. Most work reported so
far with induction of cubic phases by AMPs uses phospha-
tidylethanolamine, and the results show that some AMPs
can induce cubic-phase formation of the bicontinuous type
before the hexagonal phase transition.
In this work we report the occurrence of a different cubic
phase involving two lipids, dimyristoylphosphatidylcholine
(DMPC) and dimyristoylphosphatidylglycerol (DMPG),
induced by a peptide of the Lactoferrin family, recently
discovered by Bolscher et al., namely, LFampin 265-284,
which is particularly active against Candida albicans (8).
We have been studying peptides of this new antimicrobialdomain in Lactoferrin (9) by a variety of biophysical tech-
niques, in an attempt to characterize their mechanism of
action. We used a mixture of DMPC/DMPG at a molar ratio
of 3:1 in HEPES buffer, pH 7.4 (10 mM, NaCl 100 mM) as
a simplified model for the lipidic cell membrane. Peptide
solution in the same bufferwas added to the liposome suspen-
sion, and the mixtures were incubated for 30min at 40C and
transferred into glass capillaries or sandwiched between
Kapton foils. Small angle x-ray diffraction (SAXD) experi-
ments were performed at beamline A2 in HASYLAB at
Deutsches Elektronen-Synchrotron, Hamburg, Germany.
The sample was equilibrated at each selected temperature
for 1–5 min.
Due to the negatively charged DMPG, the mixture
DMPC/DMPG (3:1) does not show a well organized
lamellar phase (typical for DMPC), and in SAXD we
observed a broad scattering with intensity at the level of
background (not shown), compatible with unilamellar
and/or oligolamellar vesicles. Our dynamic light scattering
experiments confirmed the presence of DMPC/DMPG vesi-
cles with a size of ~250 nm. LFampin 265-284 was added to
DMPC/DMPG vesicles at molar ratios (peptide/lipid (P/L))
1:5, 1:8, and 1:14. We did not observe any changes in the
lipid diffraction pattern at the lowest ratio, 1:14 (not shown),
upon addition of the peptide. Fig. 1 shows SAXD of the 1:5
FIGURE 1 SAXD patterns for P/L mixture 1:5 (mol/mol) at
selected temperatures. (Inset) Pm3n unit cell.
FIGURE 2 SAXD patterns for P/L mixture 1:8 at selected
temperatures. The peak at position O6 is systematically absent.
(Inset) A plot of s ¼ f(sqrt(h2D k2D l2)) for all observed reflec-
tions at 24C.
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fitted by Lorentzians above a linear background. At low
temperature, we observed a cubic phase whose diffraction
maxima can be assigned to positions O2, O4, O5, O6, O8,
O13 and O18. They fit extremely well a cubic phase of
Pm3n space group symmetry. The lattice parameter a ¼
129.0 5 0.1 A˚ (at 22C) was determined as the slope of
the line s (A˚–1) ¼ f(O(h2 þ k2 þ l2) (where h, k, and l are
Miller indices) passing through the origin (0,0), with R2 ¼
0.99996. Upon further sample heating, we observed a broad
scattering underneath one to three sharp maxima in the
range 30–50C. The broad scattering can represent the
superposition of more cubic phases, or structures without
long-range order. A small peak at s ~ 0.013 A˚–1 at 50C indi-
cates the onset of the next structural changes in the mixture.
Two sharp peaks (L1 and L2) in diffractograms taken above
70C fit well with a lamellar phase. The detailed inspection
of diffractograms has revealed marked asymmetry of both
peaks, and their deconvolution (not shown) proposes the
coexistence of two phases: lamellar, with periodicity
~66 A˚, and hexagonal (including peaks marked by arrows
in Fig. 1), with lattice parameter ~77 A˚. However, the phase
transition is not completed, as indicated by the small peak
at s ~ 0.018 A˚–1, confirming that the phase composition of
the mixture is complex and the that full understanding of
the system requires study at additional P/L ratios.
The micellar cubic phase Pm3n was identified in aqueous
solutions of surfactants (10,11), lysophosphatidylcholines
(10), and gangliosides (12), but not in connection with the
AMP effect on membranes. The Pm3n phase usually
observed at high water content is supposed to consist of
discrete micelles of amphiphile arranged on the cubic lattice(Fig. 1, inset) and separated by a continuous film of water.
Two types of micelles, one spherical and one somewhat flat-
tened (12), or eight prolate micelles (13) divided into two
groups corresponding to two types of sites with different
properties, have been discussed in the literature. The posi-
tively charged AMP (nominal charge þ4) has a preferential
interaction with the negatively charged DMPG, and our
other biophysical experiments confirm that this peptide
does not partition to pure zwitterionic membranes. We
believe that it induces charge segregation, as also recently
suggested (14), and therefore, we hypothesize that we
have P/L mixed micelles and vesicles, with the flattened
form representing elongated forms of the bilayer (Fig. 1
inset, blue), less rich in DMPG, with AMP helices at the
rims (15). The observation of a lamellar phase at high
temperatures is surprising, as micellar-phase Pm3n is known
to change either to micellar solution or to hexagonal phase.
The diffractograms of the 1:8 mixture (Fig. 2) shed more
light on the appearance of the lamellar phase. At tempera-
tures below 28C, the mixture also forms a cubic phase,
Pm3n. We found the lattice parameter a ¼ 117.8 5 0.1 A˚
at 24C (Fig. 2 inset; R2 ¼ 0.999995). This value is smaller
than that obtained for the 1:5 mixture, showing that the
lattice parameters depend on the P/L ratio. In this mixture,
SAXD recognizes the lamellar-phase onset already at
29C, as indicated by two peaks whose ratio between
their s values is L2/L1¼ 2, superimposed over a broad back-
ground, similar to that observed for P/L ¼ 1:5. With
increasing temperature, the intensity of the broad back-
ground decreased. The diffractogram at 50C (Fig. 2) shows
a well ordered lamellar phase with the repeat distance d ¼
65.9 5 0.1 A˚, similar to the value retrieved at higherBiophysical Journal 101(3) L20–L22
L22 Biophysical Letterstemperature for the ratio 1:5. At 50C, DMPC multilamellar
vesicles show a repeat distance of 60.7 A˚. The higher
spacing observed compared to pure DMPC can be
accounted for either by the presence of peptide (positively
charged) between the negatively charged patches of the
membranes (formed by DMPG) or by a residual charge
imbalance of the bilayer itself. The volume fraction of the
lamellar phase in the mixture is indeed related to the molar
ratio, P/L, and that would be the reason why the lamellar
phase is less well defined for P/L ¼ 1:5. As the temperature
is raised, the cubic phase vanishes and a redistribution of
charged AMP induces massive structural changes. Most
probably, part of the mixture forms mixed lipid/peptide
aggregates, and some fraction of the peptide is bound with
lipid in the lamellar phase. The quality of the order of the
Pm3n cubic phase was found to depend on the P/L ratio in
the process of the sample heating/cooling.
Altogether, these observations suggest a complex phase
behavior, with temperature-dependent phases of different
chemical composition. It should be mentioned that the
data presented do not give complete information about the
phase diagram of the system. By its nature, SAXD identifies
only structures with long-range order, and temperature-
induced structural changes represent a dynamic process
with the experimental protocol used here. In all cases, it
should be stressed that the studied system shows remarkable
polymorphic behavior.
To the best of our knowledge, the Pm3n cubic phase has
never been reported in the context of AMP action. As the
P/L ratios tested are now known to be biologically relevant
(16), these results can thus provide experimental proof of
one of the mechanisms of antimicrobial action that has
long been proposed, namely, the micellization mechanism
that would follow an initial carpet model (7,17,18). In this
model, after an initial covering of the membrane with
peptide, when the peptide reaches a threshold value, the
membrane eventually disintegrates, being solubilized upon
formation of mixed micelles. This peptide is particularly
active against C. albicans, which is richer in phosphatidyl-
choline than phosphatidylethanolamine, and we thus hy-
pothezise that this is a possible mechanism of action
against this pathogen.ACKNOWLEDGMENTS
This research received funding from the European Commission’s 7th
Framework Program (FP7/2007-2013) under grant agreement No. 226716
(HASYLAB project II-20090024 EC), and financial support from a Funda-
c¸a˜o para a Cieˆncia e a Tecnologia/Centro de Investigac¸a˜os em Quı´mica
(Universidade do Porto) to M.B., Dutch Digestive Foundation (grant WSBiophysical Journal 101(3) L20–L2201-42) to J.G.M.B., and Ministerstva skolstva Slovenskej republiky grants
VEGA 1/0292/09 (D.U.) and SK-PT-0015-10 (D.U. and M.B.).REFERENCES and FOOTNOTES
1. Luzzati, V. 1997. Biological significance of lipid polymorphism: the
cubic phases. Curr. Opin. Struct. Biol. 7:661–668.
2. Killian, J. A., and T. K. M. Nyholm. 2006. Peptides in lipid bilayers: the
power of simple models. Curr. Opin. Struct. Biol. 16:473–479.
3. Zweytick, D., S. Tumer, ., K. Lohner. 2008. Membrane curvature
stress and antibacterial activity of lactoferricin derivatives. Biochem.
Biophys. Res. Commun. 369:395–400.
4. Fuhrmans, M., V. Knecht, and S. J. Marrink. 2009. A single bicontin-
uous cubic phase induced by fusion peptides. J. Am. Chem. Soc.
131:9166–9167.
5. Staudegger, E., E. J. Prenner,., K. Lohner. 2000. X-ray studies on the
interaction of the antimicrobial peptide gramicidin S with microbial
lipid extracts: evidence for cubic phase formation. Biochim. Biophys.
Acta. 1468:213–230.
6. Haney, E. F., S. Nathoo, ., E. J. Prenner. 2010. Induction of non-
lamellar lipid phases by antimicrobial peptides: a potential link to
mode of action. Chem. Phys. Lipids. 163:82–93.
7. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or meta-
bolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238–250.
8. van der Kraan, M. I. A., K. Nazmi, ., J. G. Bolscher. 2006. Distinct
bactericidal activities of bovine lactoferrin peptides LFampin 268-
284 and LFampin 265-284: Asp-Leu-Ile makes a difference. Biochem.
Cell Biol. 84:358–362.
9. Bolscher, J. G. M., R. Ada˜o, ., E. C. Veerman. 2009. Bactericidal
activity of LFchimera is stronger and less sensitive to ionic strength
than its constituent lactoferricin and lactoferrampinpeptides.Biochimie.
91:123–132.
10. Vargas, R., P. Mariani,., V. Luzzati. 1992. Cubic phases of lipid-con-
taining systems. The structure of phase Q223 (space group Pm3n). An
x-ray scattering study. J. Mol. Biol. 225:137–145.
11. Sakya, P., J. M. Seddon,., G. J. T. Tiddy. 1997. Micellar cubic phases
and their structural relationships: the nonionic surfactant system
C12EO12/water. Langmuir. 13:3706–3714.
12. Gulik, A., H. Delacroix,., V. Luzzati. 1995. Polymorphism of gangli-
oside-water systems: a new class of micellar cubic phases. Freeze-frac-
ture electron microscopy and x-ray scattering studies. J. Phys. II
France. 5:445–464.
13. Fontell, K., K. K. Fox, and E. Hansson. 1985. On the structure of the
cubic phase I1 in some lipid-water systems. Mol. Cryst. Liq. Cryst.
1:9–17.
14. Epand, R. M., and R. F. Epand. 2009. Lipid domains in bacterial
membranes and the action of antimicrobial agents. Biochim. Biophys.
Acta. 1788:289–294.
15. Bechinger, B. 2009. Rationalizing the membrane interactions of
cationic amphipathic antimicrobial peptides by their molecular shape.
Curr. Opin. Colloid. Interface Sci. 14:349–355.
16. Melo, M. N., R. Ferre, and M. A. R. B. Castanho. 2009. Antimicrobial
peptides: linking partition, activity and high membrane-bound concen-
trations. Nat. Rev. Microbiol. 7:245–250.
17. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms.
Nature. 415:389–395.
18. Oren, Z., and Y. Shai. 1998. Mode of action of linear amphipatic a-
helical antimicrobial peptides. Biopolymers. 47:413–491.
